Welcome to my podcast. I am Doctor Warrick Bishop, and I want to help you to live as well as possible for as long as possible. I’m a practising cardiologist, best-selling author, keynote speaker, and the creator of The Healthy Heart Network. I have over 20 years as a specialist cardiologist and a private practice of over 10,000 patients.

Podcast Summary

Introduction: Warwick Bishop hosts this episode to explore the biochemical processes involved in statin therapy, specifically examining the mevalonate pathway and its downstream effects on important molecules like coenzyme Q10 (ubiquinone) and vitamin K2. The episode focuses on whether reduced coenzyme Q10 levels from statin use contribute to muscle-related side effects and discusses emerging alternative therapies.

Key Takeaways:

• Statins work by inhibiting the mevalonate pathway, which converts acetyl-CoA through a series of reactions into cholesterol and other vital compounds.

• Both coenzyme Q10 (ubiquinone) and vitamin K2 (menaquinones) are produced downstream in the same metabolic pathway affected by statins.

• Coenzyme Q10 is essential for cellular energy production, particularly in the electron transfer pathway within mitochondria.

• A 2022 study of 80 people with statin-related muscle symptoms found no clear link between coenzyme Q10 levels and muscular symptoms.

• CoQ10 supplementation did not significantly alter plasma or muscle tissue CoQ10 levels in the study, suggesting limited efficacy for statin-induced muscle pain.

• Despite lack of strong evidence, individual patients may still benefit from CoQ10 supplementation and should be encouraged to try it if experiencing muscle discomfort.

• Bempedoic acid is an emerging alternative therapy that works upstream in the same pathway, blocking acetyl-CoA conversion at the ATP citrate liase enzyme.

• Bempedoic acid acts only in the liver, potentially avoiding the muscle-related side effects that occur with statin therapy.